We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-5.44%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$1.92B
AUM Growth
-$82.3M
Cap. Flow
-$215M
Cap. Flow %
-11.22%
Top 10 Hldgs %
52.67%
Holding
387
New
94
Increased
95
Reduced
80
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$12.5M
2
ABT icon
Abbott
ABT
+$10.5M
3
OTLK icon
Outlook Therapeutics
OTLK
+$7.71M
4
BPTH
Bio-Path Holdings Inc
BPTH
+$7.56M
5
SHPG
Shire pic
SHPG
+$5.34M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$22.6M
2
BIIB icon
Biogen
BIIB
+$7.14M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.88M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$3.22M
5
ESRX
Express Scripts Holding Company
ESRX
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 12.85%
2 Industrials 0.12%
3 Consumer Staples 0.07%
4 Consumer Discretionary 0.06%
5 Technology 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
351
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-342
Closed -$4.76M
GWPH
352
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-24,603
Closed -$2.07M
GWPH
353
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-908
Closed -$6.55M
PTLA
354
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-3,221
Closed -$6.57M
AKRX
355
CALL
DELISTED
Akorn Inc
AKRX
– –
-815
Closed -$1.92M
AKRX
356
DELISTED
Akorn Inc
AKRX
– –
-53,729
Closed -$1.26M
AKRX
357
PUT
DELISTED
Akorn Inc
AKRX
– –
-1,194
Closed -$2.81M
ACHN
358
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-105,648
Closed -$906K
ARQL
359
DELISTED
Arqule Inc
ARQL
– –
-100,000
Closed -$160K
OASM
360
DELISTED
Oasmia Pharmaceutical AB
OASM
– –
-477,836
Closed -$2.02M
SGYP
361
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-392,273
Closed -$1.08M
NXTM
362
PUT
DELISTED
NxStage Medical Inc.
NXTM
– –
-100
Closed -$150K
ESRX
363
DELISTED
Express Scripts Holding Company
ESRX
– –
-41,311
Closed -$2.84M
ESRX
364
PUT
DELISTED
Express Scripts Holding Company
ESRX
– –
-1,064
Closed -$7.31M
RNVA
365
DELISTED
Rennova Health, Inc.
RNVA
– –
-68
Closed -$23K
OPXAW
366
DELISTED
Opexa Therapeutics, Inc.
OPXAW
– –
-34,097
Closed -$2K
SPNC
367
CALL
DELISTED
Spectranetics Corp
SPNC
– –
-279
Closed -$405K
ARIA
368
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-1,265
Closed -$808K
SGYPW
369
CALL
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
– –
-9,727
Closed -$2.69M
SGYPW
370
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
– –
-285,414
Closed -$157K
TBRA
371
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
– –
-100,000
Closed -$818K
RLYP
372
DELISTED
RELYPSA INC COM
RLYP
– –
-122,905
Closed -$2.16M
NSPH
373
DELISTED
NANOSPHERE INC. COM NEW
NSPH
– –
-308,147
Closed -$243K
CRDC
374
DELISTED
CARDICA INC COM NEW (DE)
CRDC
– –
-498,600
Closed -$1.77M
MDGN.WS
375
DELISTED
MEDGENICS INC WT PUR COM EXP 03/31/16
MDGN.WS
– –
-1,564,370
Closed -$1.17M
12 13 14
15
16

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2016 Portfolio in Review

As of Q2 2016, Sabby Management held 387 positions worth $1.92B, down 4.1% from $2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sabby Management withdrew a net $215M in Q2 2016, closing 99 positions and reducing 80 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Sabby Management opened a new position in Abbott worth $10.4M.

  • Sabby Management's largest Q2 2016 buy was Abbott: 264,700 shares worth $10.4M.
  • Sabby Management added most to Regeneron Pharmaceuticals in Q2 2016, an estimated $12.5M increase.
  • Sabby Management's biggest Q2 2016 reduction was Biogen, cutting an estimated $7.14M.
  • Sabby Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2016, selling an estimated $22.6M.
  • Sabby Management's ten largest holdings make up 53% of its $1.92B portfolio in Q2 2016.
  • Sabby Management opened 94 new positions and closed 99 in Q2 2016.
  • Sabby Management's portfolio value fell 4.1% quarter-over-quarter to $1.92B.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.